ClinicalTrialsFinder

Relapsed / Refractory Solid Tumor Clinical Trials in Tianjin

1 recruitingTianjin, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors

Relapsed / Refractory Solid Tumor
Tianjin Medical University Cancer Institute and Hospital36 enrolled1 locationNCT06730659